5-(1-ETHOXY-2-BrOMOETHYL)-3',5'-DI-O-ACETYL-2'-DEOXYURIDINE;DIASTEREOMER-#1
Compound with spectra: 2 NMR
| SpectraBase Compound ID | HSMlF8OulPG |
|---|---|
| InChI | InChI=1S/C17H23BrN2O8/c1-4-25-13(6-18)11-7-20(17(24)19-16(11)23)15-5-12(27-10(3)22)14(28-15)8-26-9(2)21/h7,12-15H,4-6,8H2,1-3H3,(H,19,23,24)/t12-,13?,14+,15+/m0/s1 |
| InChIKey | IVRFTZWVJPVCFW-LJKOUDNXSA-N |
| Mol Weight | 463.28 g/mol |
| Molecular Formula | C17H23BrN2O8 |
| Exact Mass | 462.063779 g/mol |
| Enantiomer InChIKey | IVRFTZWVJPVCFW-URLJDCLXSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- 5-(1-ETHOXY-2-BrOMOETHYL)-3',5'-DI-O-ACETYL-2'-DEOXYURIDINE;DIASTEREOMER-#2
5-(1-ETHOXY-2-CHLOROETHYL)-3',5'-DI-O-ACETYL-2'-DEOXYURIDINE
5-(1-ETHOXY-2-JODOETHYL)-3',5'-DI-O-ACETYL-2'-DEOXYURIDINE;DIASTEREOMER-#1
5-(1-METHOXY-2-JODOETHYL)-3',5'-DI-O-ACETYL-2'-DEOXYURIDINE;DIASTEREOMER-#1
5-[2-(1-AZIRINYL)]-3',5'-DI-O-ACETYL-2'-DEOXYURIDINE
Telbivudine 2HFB
3'-O-ACETYLDEOXYTHYMIDINE, 5'-(4-TRITYLAMINOPHENYL)PHOSPHATE,PYRIDINIUM SALT
PHOSPHORYLATED TETRATHYMIDYLATE
1-[3,5-BIS-O-(PARA-NITROBENZOYL)-2-DEOXY-BETA-D-RIBOFURANOSYL]-5-(TRIFLUOROMETHYL)-URACIL
1-[3,5-BIS-O-(PARA-NITROBENZOYL)-2-DEOXY-ALPHA-D-RIBOFURANOSYL]-5-(TRIFLUOROMETHYL)-URACIL
5-O-[5'-O-(5''-O-LEVULINOYL-3''-THYMIDYL)-METHYL-3'-O-THYMIDYL]-METHYL-3-O-BENZOYL-THYMIDINE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and properties of 5-(1,2-dihaloethyl)-2′-deoxyuridines and related analogues | Journal of Heterocyclic Chemistry | 1991 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.